Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Cancel Anytime
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Good evening, here are the coronavirus updates you need to know tonight.

Top headlines:

  1. Trudeau won’t state a position on COVID-19 patent waivers
  2. Canada’s economy shed 207,000 jobs in April amid a third wave
  3. Here’s how to know if you’re at risk of developing a rare blood clot after the AstraZeneca shot

There have been 1,273,171 cases of COVID-19 reported in Canada. 24,529 people have died and another 1,166,428 have recovered. There are currently 3,973 patients in hospitals due to COVID-19, 1,397 of whom are in the ICU. At least 15,325,173 single doses of vaccine have been administered to date, about 85 per cent of the country’s available supply.

Story continues below advertisement

Sources: Canada data is compiled from government websites, Johns Hopkins and COVID-19 Canada Open Data Working Group; international data is from Johns Hopkins University.


Coronavirus explainers: Coronavirus in maps and chartsTracking vaccine dosesLockdown rules and reopeningVaccine distribution planFour vaccines approved in CanadaEssential resources


Photo of the day

Spectators look on during the first COVID-19 proof test event at The Petit Theatre in Spa, on May 7, 2021, as the place receives 220 persons, half of the regular capacity.

JOHN THYS/AFP/Getty Images


Coronavirus in Canada


In Ottawa, Prime Minister Justin Trudeau would not state a position on the subject of patent waivers for COVID-19 vaccines.

  • The Prime Minister avoided directly responding to questions from reporters and instead said that Canada is working to build a consensus at the World Trade Organization, where the issue is being debated.
  • A coalition of members of Parliament from different parties held a news conference on Friday urging Trudeau to support the waiver first proposed by India and South Africa in October.
  • The measure has the support of more than 100 countries, but is languishing at the WTO, where it requires unanimous support from 164 members to pass.

COVID-19 vaccines: I got my first shot of the AstraZeneca COVID-19 vaccine. How do I know if I’m at risk of developing a rare blood clot?

COVID-19 vaccines: Despite mixed messages on the AstraZeneca COVID-19 vaccine, many are still eager to get their shot.

COVID-19 and Ramadan: For Muslims around the world, this Ramadan marks the second during the COVID-19 pandemic. In Canada, it comes squarely in the third wave, with gatherings held in ways that respect pandemic restrictions.


Coronavirus around the world

  • The World Health Organization has approved emergency use of the COVID-19 vaccine manufactured by China’s Sinopharm. The move opens the possibility that millions of doses of the shot could be included in the UN-backed COVAX program.
  • As more than 4,000 people die of COVID-19 each day in India, the number of “COVID orphans” – young children who have lost parents to coronavirus – is growing by the dozens every day.

Coronavirus and business

After postponing its annual marketing event, Prime Day, in Canada over workplace outbreaks of COVID-19, Amazon did not respond to questions about how many of its workers are currently infected or isolating because of COVID-19. The company declined to respond to questions about access to paid sick-leave benefits.

Story continues below advertisement

  • Peel Region, which has one of the highest community COVID-19 positivity rates in Canada, is home to a number of Amazon’s major fulfillment centres.
  • The region’s public health unit partly closed three Amazon fulfillment centres – two in Brampton and one in Caledon – in the last two weeks under its order to shut workplaces with five or more cases of COVID-19.

Also today: Canada’s labour recovery saw a setback as the economy shed 207,000 jobs in April amid the third wave of COVID-19.

And: The head of the World Trade Organization says that support from the United States on COVID-19 vaccine patent waivers will encourage further talks on the issue.


Globe opinion


More reporting


Information centre

Sources: Canada data are compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data are from Johns Hopkins.

What are we missing? Email us: audience@globeandmail.com. Do you know someone who needs this newsletter? Send them to our Newsletters page.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Comments are closed

We have closed comments on this story for legal reasons or for abuse. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies